Skin-to-Skin Contact and Lavender Aromatherapy After Elective Cesarean: Effects on Cortisol and Early Breastfeeding
LAVENDER-SSC
Elective Cesarean Section Postpartum Structured Mother-Infant Skin-to-Skin Contact With Maternal Lavender Aromatherapy: Effects on Maternal Salivary Cortisol, IgA Levels and Early Breastfeeding Outcomes - A Randomized Controlled Trial
1 other identifier
interventional
150
1 country
1
Brief Summary
This single-center randomized controlled clinical trial will evaluate the effects of structured early postpartum mother-infant skin-to-skin contact, with or without maternal lavender aromatherapy, after elective cesarean section on maternal stress biomarkers and early breastfeeding outcomes. The study will enroll 150 term pregnant women scheduled for elective cesarean section under spinal anesthesia at Ataturk University Research Hospital. Participants will be randomized into three groups: routine postoperative care, structured skin-to-skin contact, and structured skin-to-skin contact combined with inhalational lavender aromatherapy. The primary outcome is the change in maternal salivary cortisol level from immediately after birth to 60 minutes postpartum. Secondary outcomes include maternal salivary IgA levels, state anxiety scores, postoperative pain and nausea, time to first analgesic requirement, early breastfeeding initiation and success, LATCH scores, neonatal axillary temperature, cumulative duration and continuity of skin-to-skin contact, maternal satisfaction, and the need for mother-infant separation within the first 2 hours postpartum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2026
CompletedFirst Posted
Study publicly available on registry
May 28, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
ExpectedMay 28, 2026
May 1, 2026
Same day
May 21, 2026
May 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in maternal salivary cortisol level
Difference in maternal salivary cortisol concentration between immediately after birth (T0) and 60 minutes postpartum (T1), compared among the three study groups.
From immediately after birth (T0) to 60 minutes postpartum (T1)
Secondary Outcomes (11)
Maternal salivary IgA level
From immediately after birth (T0) to 60 minutes postpartum (T1)
State anxiety score (STAIS-5)
Preoperative baseline to 120 minutes postpartum (T2)
Postoperative pain intensity (VAS)
60 minutes (T1) and 120 minutes (T2) postpartum
Postoperative nausea and vomiting
60 minutes (T1) and 120 minutes (T2) postpartum
Time to first analgesic requirement
From end of surgery to first analgesic requirement within the first 24 hours postoperatively
- +6 more secondary outcomes
Study Arms (3)
Routine Care
NO INTERVENTIONParticipants in this arm will receive routine intraoperative and postoperative care after elective cesarean section under spinal anesthesia, according to the standard practice of Ataturk University Research Hospital. No structured early skin-to-skin contact protocol or lavender aromatherapy will be applied beyond usual care.
Structured Skin-to-Skin Contact
EXPERIMENTALParticipants in this arm will receive a structured early postpartum mother-infant skin-to-skin contact protocol after elective cesarean section under spinal anesthesia. Following delivery and clinical stabilization of the mother and newborn, the naked neonate will be placed prone on the mother's bare chest, covered with a warm blanket, and maintained in continuous skin-to-skin contact during the first 60 minutes postpartum as tolerated. Cumulative duration of skin-to-skin contact, number of interruptions, and reasons for interruption will be recorded.
Structured Skin-to-Skin Contact Plus Lavender Aromatherapy
EXPERIMENTALParticipants in this arm will receive the same structured early postpartum mother-infant skin-to-skin contact protocol as in the skin-to-skin only group, combined with maternal inhalational lavender aromatherapy. Lavender essential oil will be administered via inhalation using a cotton pad or similar carrier placed near the mother's face during the early postpartum period, starting shortly after surgery and maintained during the first 60 minutes postpartum as tolerated, according to the study protocol. Tolerance to aromatherapy and any adverse reactions will be monitored and recorded.
Interventions
A structured early postpartum skin-to-skin contact protocol applied after elective cesarean section under spinal anesthesia. Following stabilization of the mother and newborn, the naked neonate is placed prone on the mother's bare chest and covered with a warm blanket. Continuous skin-to-skin contact is maintained during the first 60 minutes postpartum as tolerated, and cumulative duration, number of interruptions, and reasons for interruption are recorded.
Maternal inhalational aromatherapy using lavender essential oil during the early postpartum period after elective cesarean section. Lavender oil is applied via inhalation using a cotton pad or similar carrier placed near the mother's face during the first 60 minutes postpartum, in combination with the structured skin-to-skin contact protocol, as tolerated. Tolerance to aromatherapy and any adverse reactions are monitored and recorded.
Eligibility Criteria
You may qualify if:
- Female participants aged 18 to 40 years
- Term singleton pregnancy (≥37 weeks of gestation)
- Scheduled for elective cesarean section
- ASA physical status I-II
- Planned spinal anesthesia
- Clinically stable mother and newborn immediately after birth
- Ability to initiate breastfeeding in the early postpartum period
- Provision of written informed consent
You may not qualify if:
- Emergency cesarean section
- General anesthesia or conversion from spinal to general anesthesia
- Need for neonatal resuscitation or severe neonatal compromise
- Maternal hemodynamic instability or massive hemorrhage
- Major fetal congenital anomalies
- Known allergy or intolerance to lavender
- Severe asthma or intolerance to strong odors
- Major psychiatric disorders
- Serious endocrine diseases affecting stress hormone regulation
- Clinical conditions that preclude breastfeeding
- Contraindications to spinal anesthesia
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ataturk University
Erzurum, 25240, Turkey (Türkiye)
Related Publications (3)
Namba Y, Smith JB, Fox GS, Challis JR. Plasma cortisol concentrations during Caesarean section. Br J Anaesth. 1980 Oct;52(10):1027-32. doi: 10.1093/bja/52.10.1027.
PMID: 7437211RESULTNouira M, Souayeh N, Kanzari SA, Rouis H, Lika A, Mbarki C, Rahali FZ, Bettaieb H. Aromatherapy Using Lavender Oil Effectiveness on Pain and Anxiety After C-Section: A Randomized Controlled Trial. J Epidemiol Glob Health. 2024 Dec;14(4):1536-1544. doi: 10.1007/s44197-024-00305-6. Epub 2024 Oct 14.
PMID: 39400653RESULTWidstrom AM, Brimdyr K, Svensson K, Cadwell K, Nissen E. Skin-to-skin contact the first hour after birth, underlying implications and clinical practice. Acta Paediatr. 2019 Jul;108(7):1192-1204. doi: 10.1111/apa.14754. Epub 2019 Mar 13.
PMID: 30762247RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
kamber kasali, PhD
Atatürk University Faculty of Medicine, Department of Biostatistics, Erzurum, Turkey
- STUDY CHAIR
gamzenur cimilli senocak, MD
Atatürk University Faculty of Medicine, Department of Obstetrics and Gynecology, Erzurum, Turkey
- STUDY CHAIR
orhan buyukkurt, MD
Ataturk University Faculty of Medicine, Department of Anesthesiology and Reanimation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Open-label to participants and care providers; laboratory personnel and statistical analysis team will be blinded to group allocation when assessing biochemical and outcome data (outcomes assessor-masked).
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Anesthesiology and Reanimation
Study Record Dates
First Submitted
May 21, 2026
First Posted
May 28, 2026
Study Start
June 1, 2026
Primary Completion
June 1, 2026
Study Completion (Estimated)
December 30, 2027
Last Updated
May 28, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
There is no current plan to share individual participant data (IPD) outside the study team due to institutional and national data protection regulations.